Venus Concept Inc

NASDAQ:VERO   3:53:52 PM EDT
0.70
+0.04 (+5.81%)
Products

Venus Concept Submits FDA 510(K) Related To The Use Of Its Aime Next Generation Robotic Technology For Tissue Excision And Skin Resurfacing

Published: 03/31/2022 21:14 GMT
Venus Concept Inc (VERO) - Venus Concept Submits FDA 510(k) Related to the Use of Its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing.
Venus Concept Inc - Look Forward to Beginning a Limited Release in Q4 of 2022.